Skip to contents

  1. Cooperberg, Matthew R.; Faino, Anna V; Newcomb, Lisa F; Carroll, Peter; Kearns, James T; Brooks, James D.; Fabrizio, Michael; Gleave, Martin; Morgan, Todd Matthew; Dash, Atreya; Nelson, Peter; Thompson, Ian Murchie; Wagner, Andrew; Lin, Daniel W.; Zheng, Yingye

    When can active surveillance be less active? Prediction of long-term nonreclassification for men with low-risk prostate cancer

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2018

    Published in: Journal of Clinical Oncology

  2. Synold, Timothy W.; Plets, Melissa; Tangen, Catherine M.; Heath, Elisabeth I.; Palapattu, Ganesh S.; Mack, Philip C.; Stein, Mark N.; Meng, Maxwell V.; Lara, Primo; Vogelzang, Nicholas J.; Thompson, Ian Murchie; Ryan, Christopher W.

    Everolimus (EVE) exposure as a predictor of toxicity (Tox) in renal cell cancer (RCC) patients (Pts) in the adjuvant setting: Results of a pharmacokinetic analysis for SWOG S0931 (EVEREST), a phase III study (NCT01120249)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2017

    Published in: Journal of Clinical Oncology

  3. Singh, Parminder; Catherine, Tangen; Lerner, Seth P.; McConkey, David; Plets, Melissa; Lucia, M. Scott; Woods, Michael; Bivalacqua, Trinity; Kassouf, Wassim; Bangs, Richard Carlton; Thompson, Ian Murchie; Black, Peter C.

    S1605: Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2017

    Published in: Journal of Clinical Oncology

  4. Unger, Joseph M.; Barlow, William E.; Tangen, Catherine M.; Ramsey, Scott David; Thompson, Ian Murchie; Klein, Eric A.; LeBlanc, Michael Leo; Blanke, Charles David; Goodman, Phyllis J.; Minasian, Lori M.; Hershman, Dawn L.

    The scientific impact and value of large, NCI-sponsored randomized phase III cancer prevention trials

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2017

    Published in: Journal of Clinical Oncology

  5. Kearns, James T; Faino, Anna V; Newcomb, Lisa F; Brooks, James D.; Carroll, Peter; Dash, Atreya; Ellis, William J; Fabrizio, Michael; Gleave, Martin; Morgan, Todd Matthew; Nelson, Peter S; Thompson, Ian Murchie; Wagner, Andrew; Zheng, Yingye; Lin, Daniel W.

    The use of five-alpha reductase inhibitors and their association with reclassification and pathologic outcomes in the Canary Prostate Active Surveillance Study (PASS)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2017

    Published in: Journal of Clinical Oncology

  6. Lerner, Seth P.; Li, Hongli; Svatek, Robert Scott; Koppie, Theresa M.; Alva, Ajjai Shivaram; La Rosa, Francisco G.; Bangs, Rick; Pal, Sumanta Kumar; Daneshmand, Siamak; Kibel, Adam S.; Canter, Daniel J.; Tangen, Catherine M.; Thompson, Ian Murchie

    Prerandomization factors and utilization of neoadjuvant chemotherapy in a clinical trial of extended versus standard pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2014

    Published in: Journal of Clinical Oncology

  7. Agarwal, Neeraj; Tangen, Catherine M.; Hussain, Maha; Lara, Primo; Higano, Celestia S.; Vaena, Daniel A.; MacVicar, Gary R.; Li, Hongli; Crispino, Tony; Quinn, David I.; Vogelzang, Nicholas J.; Thompson, Ian Murchie

    SWOG S1216: A phase III randomized trial comparing androgen deprivation therapy (ADT) plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed metastatic hormone-sensitive prostate cancer (HSPC) (NCT01809691)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2014

    Published in: Journal of Clinical Oncology

  8. Brooks, James D.; Brown, Elissa C.; Cooperberg, Matthew R.; Newcomb, Lisa F.; Carroll, Peter; Feng, Ziding; Gleave, Martin Edwin; Lance, Raymond; Sanda, Martin G.; Thompson, Ian Murchie; Wei, John Thomas; Nelson, Peter; Lin, Daniel W.

    Association of declining PSA values with a lower risk of progression in the Canary Prostate Cancer Active Surveillance Study (PASS)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2013

    Published in: Journal of Clinical Oncology

  9. Moinpour, Carol; Berry, Donna Lynn; Ely, Benjamin; Tangen, Catherine M.; Higano, Celestia S.; Picus, Joel; Schellhammer, Paul F.; Skinner, Eila C.; Cher, Michael L.; Thompson, Ian Murchie; Hussain, Maha

    Preliminary quality-of-life outcomes for SWOG-9346: Intermittent androgen deprivation in patients with hormone-sensitive metastatic prostate cancer (HSM1PC)—Phase III

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2012

    Published in: Journal of Clinical Oncology

  10. Quinn, David I.; Tangen, Catherine M.; Hussain, Maha; Lara, Primo; Goldkorn, Amir; Garzotto, Mark; Mack, Philip C.; Carducci, Michael Anthony; Monk, J. P.; Twardowski, Przemyslaw; Van Veldhuizen, Peter J.; Agarwal, Neeraj; Higano, Celestia S.; Vogelzang, Nicholas J.; Thompson, Ian Murchie

    SWOG S0421: Phase III study of docetaxel (D) and atrasentan (A) versus docetaxel and placebo (P) for men with advanced castrate resistant prostate cancer (CRPC)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2012

    Published in: Journal of Clinical Oncology

  11. Lin, Daniel W.; Newcomb, Lisa F; Brown, Elissa C; Brooks, James D; Carroll, Peter; Feng, Ziding; Gleave, Martin E.; Lance, Ray; Sanda, Martin G.; Thompson, Ian Murchie; Wei, John; Nelson, Peter

    Urinary TMPRSS2: Use of ERG and PCA3 to predict tumor volume and Gleason grade in an active surveillance cohort—Results from the Canary/EDRN Prostate Active Surveillance Study

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2012

    Published in: Journal of Clinical Oncology

  12. Halabi, Susan; Dutta, Sandipan; Tangen, Catherine M.; Rosenthal, Mark; Petrylak, Daniel Peter; Thompson, Ian Murchie; Chi, Kim N.; De Bono, Johann S.; Fandi, Abderrahim; Araujo, John C.; Eisenberger, Mario A.; Logothetis, Christopher; Quinn, David I.; Fizazi, Karim; Higano, Celestia S.; George, Daniel J.; Morris, Michael J.; Small, Eric Jay; Tannock, Ian; Kelly, William Kevin

    Overall survival between African-American (AA) and Caucasian (C) men with metastatic castration-resistant prostate cancer (mCRPC)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2018

    Published in: Journal of Clinical Oncology

  13. Flaig, Thomas W.; Tangen, Catherine; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M. Scott; McConkey, David; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I.; Bangs, Rick; MacVicar, Gary R.; Bastos, Bruno R.; Fowles, Jared; Gustafson, Daniel; Plets, Melissa; Thompson, Ian Murchie; Lerner, Seth P.

    SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2022

    Published in: Journal of Clinical Oncology

  14. Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Morrison, Gareth J.; Cunha, Alexander; Xu, Tong; Pinski, Jacek K.; Ingles, Sue A.; Triche, Timothy; Harzstark, Andrea L.; Kohli, Manish; MacVicar, Gary R.; Vaena, Daniel A.; Crispino, Anthony W.; McConkey, David J.; Lara, Primo N.; Hussain, Maha H.A.; Quinn, David I.; Vogelzang, Nicholas J.; Thompson, Ian Murchie; Agarwal, Neeraj

    Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Association for Cancer Research (AACR), 2021

    Published in: Clinical Cancer Research

  15. Singh, Parminder; Efstathiou, Jason A.; Tangen, Catherine; Jhavar, Sameer G.; Hahn, Noah M.; Costello, Brian Addis; Delacroix, Scott Edward; Tripathi, Abhishek; Sachdev, Sean; Gills, Jessie; Jani, Ashesh B.; Bangs, Rick; Plets, Melissa; Vogelzang, Nicholas J.; Thompson, Ian Murchie; Feng, Felix Y; Lerner, Seth P.

    INTACT (S/N1806) phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle-invasive bladder cancer: Safety update on first 73 patients

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2021

    Published in: Journal of Clinical Oncology

  16. Pal, Sumanta K.; Tangen, Catherine; Thompson, Ian Murchie; Haas, Naomi B.; George, Daniel J.; Heng, Daniel Yick Chin; Shuch, Brian M.; Stein, Mark N.; Tretiakova, Maria S.; Humphrey, Peter; Adeniran, Adebowale; Narayan, Vivek; Bjarnason, Georg A.; Vaishampayan, Ulka N.; Alva, Ajjai Shivaram; Zhang, Tian; Cole, Scott Wesley; Plets, Melissa; Wright, John; Lara, Primo "Lucky" N.

    Sunitinib versus cabozantinib, crizotinib or savolitinib in metastatic papillary renal cell carcinoma (pRCC): Results from the randomized phase II SWOG 1500 study

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2021

    Published in: Journal of Clinical Oncology

  17. Agarwal, Neeraj; Tangen, Catherine; Hussain, Maha H. A.; Gupta, Shilpa; Plets, Melissa; Lara, Primo "Lucky" N.; Harzstark, Andrea; Twardowski, Przemyslaw; Paller, Channing Judith; Zylla, Dylan M.; Zibelman, Matthew R.; Levine, Ellis Glenn; Roth, Bruce J.; Goldkorn, Amir; Vaena, Daniel A.; Kohli, Manish; Crispino, Tony; Vogelzang, Nicholas J.; Thompson, Ian Murchie; Quinn, David I.

    SWOG S1216: A phase III randomized trial comparing androgen deprivation therapy (ADT) plus TAK-700 with ADT plus bicalutamide in patients (pts) with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) (NCT01809691)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2021

    Published in: Journal of Clinical Oncology

  18. Lerner, Seth P.; McConkey, David James; Tangen, Catherine; Meeks, Joshua J; Flaig, Thomas W.; Hua, Xing; Daneshmand, Siamak; Alva, Ajjai Shivaram; Lucia, M. Scott; Theodorescu, Dan; Goldkorn, Amir; Milowsky, Matthew I.; Choi, Woonyoung; Bangs, Richard Carlton; Gustafson, Daniel; Thompson, Ian Murchie

    Association of molecular subtypes with pathologic response in a phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy (NAC) for localized, muscle-invasive bladder cancer (SWOG S1314; NCT02177695)

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2020

    Published in: Journal of Clinical Oncology

  19. Goldkorn, Amir; Tangen, Catherine; Plets, Melissa; Morrison, Gareth; Cunha, Alexander; Xu, Tong; Pinski, Jacek K.; Ingles, Sue A.; Triche, Timothy; MacVicar, Gary R.; Vaena, Daniel A.; Crispino, Anthony W.; McConkey, David James; Lara, Primo; Hussain, Maha H. A.; Quinn, David I.; Vogelzang, Nicholas J.; Thompson, Ian Murchie; Agarwal, Neeraj

    Baseline circulating tumor cell (CTC) count as a prognostic marker of PSA response and progression in metastatic castrate sensitive prostate cancer (mCSPC): Results from SWOG S1216, a phase III randomized trial of androgen deprivation plus orteronel (cyp17 inhibitor) or bicalutamide

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2020

    Published in: Journal of Clinical Oncology

  20. Singh, Parminder; Tangen, Cathy; Efstathiou, Jason A.; Lerner, Seth P.; Jhavar, Sameer G.; Hahn, Noah M.; Costello, Brian Addis; Sridhar, Srikala S.; Du, Weliang; Meeks, Joshua J.; Faltas, Bishoy Morris; Grivas, Petros; Feng, Felix Y; Chen, Ronald C.; Morgans, Alicia K.; Gupta, Amit; Bangs, Richard Carlton; Winter, Kathryn A.; Vogelzang, Nicholas J.; Thompson, Ian Murchie

    INTACT: Phase III randomized trial of concurrent chemoradiotherapy with or without atezolizumab in localized muscle invasive bladder cancer—SWOG/NRG1806

    Articles
    View online
    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2020

    Published in: Journal of Clinical Oncology